Luke Boulanger

Summary

Publications

  1. pmc A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients
    Luke Boulanger
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, MA, USA
    BMC Health Serv Res 9:111. 2009
  2. doi Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain
    Luke Boulanger
    Health Economic Research and Quality of Life Evaluation Services HERQuLES, Abt Bio Pharma Solutions, Inc, Lexington, MA 02451, USA
    Curr Med Res Opin 25:1763-73. 2009
  3. doi Predictors of pain medication selection among patients diagnosed with fibromyalgia
    Luke Boulanger
    United BioSource Corporation, Lexington, Massachusetts, USA
    Pain Pract 12:266-75. 2012
  4. doi Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies
    Ning Wu
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts, USA
    Pain Pract 11:48-56. 2011
  5. ncbi One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events
    Shih Yin Chen
    Health Economics, United BioSource Corporation, 430 Bedford St, Ste 300, Lexington, MA 02420, USA
    J Manag Care Pharm 19:291-301. 2013
  6. doi Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Am J Geriatr Pharmacother 10:273-83. 2012
  7. doi Medical resource use and costs related to central precocious puberty: a retrospective cohort study
    Shih Yin Chen
    United BioSource Corporation, Lexington, Massachusetts 02420, USA
    Endocr Pract 18:519-28. 2012
  8. doi The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Respir Med 102:1248-56. 2008
  9. doi Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
    Shih Yin Chen
    Evidera, 430 Bedford Street Suite 300, Lexington, MA 02420, USA
    BMC Health Serv Res 14:80. 2014
  10. doi Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension
    Aaron Waxman
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Med Econ 16:298-306. 2013

Collaborators

Detail Information

Publications21

  1. pmc A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients
    Luke Boulanger
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, MA, USA
    BMC Health Serv Res 9:111. 2009
    ..No study has examined the differences in economic outcomes depending on the presence of comorbid DA disorders...
  2. doi Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain
    Luke Boulanger
    Health Economic Research and Quality of Life Evaluation Services HERQuLES, Abt Bio Pharma Solutions, Inc, Lexington, MA 02451, USA
    Curr Med Res Opin 25:1763-73. 2009
    ....
  3. doi Predictors of pain medication selection among patients diagnosed with fibromyalgia
    Luke Boulanger
    United BioSource Corporation, Lexington, Massachusetts, USA
    Pain Pract 12:266-75. 2012
    ..However, the factors associated with each treatment initiation have not been well established. This study assessed factors that were associated with the use of duloxetine vs. other pain medications among patients with fibromyalgia...
  4. doi Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies
    Ning Wu
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts, USA
    Pain Pract 11:48-56. 2011
    ..This retrospective cohort study assessed subsequent opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain (DPNP) who initiated duloxetine vs. other standard of care (SOC) treatments...
  5. ncbi One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events
    Shih Yin Chen
    Health Economics, United BioSource Corporation, 430 Bedford St, Ste 300, Lexington, MA 02420, USA
    J Manag Care Pharm 19:291-301. 2013
    ..However, its long-term use is complicated by the need to manage the drug within a narrow therapeutic range and by possible food and drug interactions...
  6. doi Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Am J Geriatr Pharmacother 10:273-83. 2012
    ..Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and disproportionately affects the elderly...
  7. doi Medical resource use and costs related to central precocious puberty: a retrospective cohort study
    Shih Yin Chen
    United BioSource Corporation, Lexington, Massachusetts 02420, USA
    Endocr Pract 18:519-28. 2012
    ..To evaluate the economic burden of central precocious puberty (CPP) by examining direct health care resource utilization and costs...
  8. doi The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population
    Joseph Menzin
    Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
    Respir Med 102:1248-56. 2008
    ..Although the economic burden of COPD has gained attention in recent years, data on the costs of COPD among U.S. Medicare beneficiaries are lacking...
  9. doi Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
    Shih Yin Chen
    Evidera, 430 Bedford Street Suite 300, Lexington, MA 02420, USA
    BMC Health Serv Res 14:80. 2014
    ..Atrial fibrillation (AF) and heart failure (HF) are both common comorbid conditions of elderly patients with acute coronary syndrome (ACS), but published data on their associated clinical and economic outcomes are limited...
  10. doi Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension
    Aaron Waxman
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Med Econ 16:298-306. 2013
    ..To assess factors associated with adherence to phosphodiesterase type 5 inhibitors (PDE5Is) in the management of pulmonary arterial hypertension (PAH)...
  11. doi Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy
    Dale A Rublee
    Pfizer, Inc, New York, NY 10017, USA
    Am J Ther 19:24-32. 2012
    ..82). Atorvastatin discontinuation rates were high 1 year after treatment initiation. Patients who adhered to atorvastatin treatment were at lower CV risk. Quality-of-care interventions should target improvements to therapy persistence...
  12. doi Assessing achievement and maintenance of glycemic control by patients initiating basal insulin
    Ning Wu
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 28:1647-56. 2012
    ..Describe characteristics of diabetic patients who initiated basal insulin and assess their glycemic control...
  13. pmc Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Clinicoecon Outcomes Res 5:181-8. 2013
    ..To evaluate the clinical and economic burden of acute coronary syndrome (ACS), a common cardiovascular illness, in the Medicare population...
  14. doi Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA, USA
    Curr Med Res Opin 28:493-501. 2012
    ..To assess outcomes associated with oral anti-diabetic drug (OAD) treatment concordant with guidelines from the National Kidney Foundation (NKF) among type 2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD)...
  15. doi Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudy
    Joseph Menzin
    Boston Health Economics, Inc, Waltham, Massachusetts, USA
    Appl Health Econ Health Policy 6:157-62. 2008
    ..To analyse 2-year hospitalization and cost data collected during a prospective, double-blind, randomized, controlled trial comparing amlodipine, enalapril and placebo in normotensive patients with coronary artery disease (CAD)...
  16. doi The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy
    Shih Yin Chen
    Health Economic Research and Quality of Life Evaluation, Abt Bio Pharma Solutions, Inc, Lexington, Massachusetts 02451, USA
    Pain Pract 10:530-9. 2010
    ..To examine the relationship between average daily dose (ADD) of duloxetine, adherence to therapy, and health-care costs among patients with diabetic peripheral neuropathic pain (DPNP)...
  17. ncbi Moving branded statins to lowest copay tier improves patient adherence
    Shih Yin Chen
    430 Bedford St, Lexington, MA 02420, USA
    J Manag Care Pharm 20:34-42. 2014
    ..Their effectiveness could be compromised in actual practice when patients are not adherent to the treatments. Higher copayments have been shown to be associated with lower adherence to statins...
  18. doi Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States
    Shih Yin Chen
    United BioSource Corporation, Lexington, MA 02420, USA
    J Med Econ 16:240-8. 2013
    ..To assess the economic burden in direct healthcare utilization and costs for refractory epileptic patients with partial onset seizures (POS) and assess the antiepileptic drug (AED) treatment patterns among these patients...
  19. doi Antimuscarinic use among individuals with urinary incontinence who reside in long-term care facilities
    Ning Wu
    Center for Health Economics and Science Policy, United BioSource Corporation, 430 Bedford Street, Suite 300, Lexington, MA, 02420, USA
    Int Urol Nephrol 46:285-96. 2014
    ..To assess appropriateness of antimuscarinic use in long-term care facilities (LTCFs) among treated and untreated urinary incontinence (UI) residents from 2007 to 2009...
  20. doi Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole
    Michelle Friedman
    United BioSource Corporation, Lexington, MA, USA
    J Med Econ 16:449-60. 2013
    ..This study assesses the operational advantages and laboratory efficiency associated with the use of regadenoson compared to adenosine and dipyridamole...
  21. ncbi Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data Bank
    Luke Boulanger
    Boston Health Economics, Inc, Waltham, MA 02451, USA
    Am Surg 73:1269-74. 2007
    ..05). In both blunt and penetrating trauma cases, serious hemorrhage is significantly associated with excess mortality, longer hospital stays, and higher costs...